These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23993459)

  • 41. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
    Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
    Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of preoperative lymphoscintigraphy and thin-slice computed tomography on sentinel node assessment: metastatic sentinel node in a lateral paramammary lesion out of axillary nodes from breast cancer.
    Hikino H; Yasui K; Ozaki N; Nagaoka S
    Radiat Med; 2006 Oct; 24(8):583-6. PubMed ID: 17041796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
    Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
    Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
    Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
    Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequency and Predictors of Axillary Lymph Node Metastases in Iranian Women with Early Breast Cancer.
    Sandoughdaran S; Malekzadeh M; Mohammad Esmaeil ME
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1617-1620. PubMed ID: 29936787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result.
    Lim GH; Upadhyaya VS; Acosta HA; Lim JMA; Allen JC; Leong LCH
    Eur J Surg Oncol; 2018 Jul; 44(7):945-950. PubMed ID: 29705286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sentinel lymph node biopsy in the treatment of breast cancer. Experience in 527 cases.
    Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; De Luca R; Irlandese E; Gili S; Lo Schiavo F
    Minerva Chir; 2007 Apr; 62(2):93-9. PubMed ID: 17353851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review.
    Lee MC; Plews R; Rawal B; Kiluk JV; Loftus L; Laronga C
    Ann Surg Oncol; 2012 Jun; 19(6):1818-24. PubMed ID: 22203185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endosalpingiosis of axillary sentinel lymph node: a mimic of metastatic breast carcinoma.
    Ozerdem U; Hoda SA
    Breast J; 2015; 21(2):194-5. PubMed ID: 25583152
    [No Abstract]   [Full Text] [Related]  

  • 52. Sentinel lymph node biopsy is precise after primary systemic therapy in stage II-III breast cancer patients.
    Reitsamer R; Menzel C; Glueck S; Rettenbacher L; Weismann C; Hutarew G
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():286-90. PubMed ID: 20853048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Sentinel lymph node biopsy in breast cancer].
    Rody A; Solbach C; Kaufmann M
    Chirurg; 2004 Aug; 75(8):767-73. PubMed ID: 15221088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
    Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
    Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective validation study of sentinel lymph node biopsy in multicentric breast cancer: SMMaC trial.
    van la Parra RF; de Roos WK; Contant CM; Bavelaar-Croon CD; Barneveld PC; Bosscha K
    Eur J Surg Oncol; 2014 Oct; 40(10):1250-5. PubMed ID: 24685336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Squamous inclusion cyst in a sentinel axillary lymph node associated with breast malignancy.
    Haroon S; Faridi N; Fatima S
    J Coll Physicians Surg Pak; 2012 Jan; 22(1):50-2. PubMed ID: 22237193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Re: Sakorafas GH, Geraghty J, Pavlakis G. The clinical significance of axillary lymph node micrometastases in breast cancer. Eur J Surg Oncol 2004;30(8):807-16.
    Meijnen P; Rutgers EJ
    Eur J Surg Oncol; 2005 Oct; 31(8):927. PubMed ID: 15951151
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical Experience of a Primary Accessory Breast Cancer Patient].
    Ikarashi M; Nagahashi M; Endo M; Otani A; Tsuchida J; Moro K; Niwano T; Yamaura K; Toshikawa C; Hasegawa M; Nakajima M; Sakata J; Kobayashi T; Kameyama H; Wakai T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1104-1106. PubMed ID: 29394548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
    Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
    Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Re: international multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
    Chen K; Zhu L; Song E; Su F
    J Natl Cancer Inst; 2013 Oct; 105(19):1513-4. PubMed ID: 23985140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.